Effects of Hypoglycemia on Developmental Outcome in Children With Congenital Hyperinsulinism

References 

1. Brown L. Hypoglycemia, brain injury, and developmental consequences. In: Symposium conducted at the Congenital Hyperinsulinism Family Conference, Philadelphia, PA. 2003, June;
2. Bruininks RH, Woodcock RW, Weatherman RF, Hill BK. Scales of independent behavior—Revised. Itasca, IL: Riverside Publishing; 1996;
3. Cornblath M, Nakamura H, Zeiterstrom R, Kobayashi N. An international symposium on neonatal hypoglycemia: Thirty years later. Does it injure the neonatal brain?. Acta Paediatrica Japonica. 1997;39:S1–S11
4. Cornblath M, Schwartz R, Aynsley-Green A, Lloyd JK. Hypoglycemia in infancy: The need for a rational definition. Pediatrics. 1990;85:834–837
   • MEDLINE
5. Dacou-Voutetakis C, Psychou F, Maniati-Christidis MM. Persistent hyperinsulinemic hypoglycemia of infancy: Long-term results. Journal of Pediatric Endocrinology and Metabolism. 1998;11:131–141
6. de Lonlay P, Fournet J-C, Rahier J, Gross-Morand M-S, Poggi-Travert R, Foussier V, et al. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. Journal of Clinical Investigation. 1997;4:802–807
7. Glaser B, Chiu KC, Anker R, Nestorowicz A, Landau H, Ben-Bassat H, et al. Familial hyperinsulinism maps to chromosome 11p14-15.1, 30 cM centromeric to the insulin gene. Nature Genetics. 1994;7:185–188
   • MEDLINE
   • CrossRef
8. Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A, et al. Familial hyperinsulinism caused by an activating glucokinase mutation. New England Journal of Medicine. 1998;338:226–230
9. Glaser B, Thornton P, Otonkoski T, Junien C. Genetics of neonatal hyperinsulinism. Archives of Diseases in Childhood. Fetal Neonatal Edition. 2000;82:F79–F86
10. Gregory JW, Aynsley-Green A. The definition of hypoglycaemia. Baillière's Clinical Endocrinology and Metabolism. 1993;7:587–590
    • MEDLINE
    • CrossRef
11. Hoe FM, Thornton P, Steinmuller LA, Steinkrauss L, Bhatia P, Stanley CA. Perinatal stress hyperinsulinism differs from genetic hyperinsulinism due to mutations in KA_TP channel or glutamate dehydrogenase. In: Symposium conducted at the Pediatric Academic Society, Seattle, WA. 2003, May;
12. Horev Z, Ipp M, Levey P, Daneman D. Familial hyperinsulinism: Successful conservative management. Journal of Pediatrics. 1991;119:717–720
13. Huopio H, Reimann F, Ashfield R, Komulainen J, Lenko H-L, Rahier J, et al. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. Journal of Clinical Investigation. 2000;106:897–906
14. Jack MM, Greer RM, Thronsett MJ, Walker RM, Bell JR, Choong C, et al. The outcome in Australian children with hyperinsulinism of infancy: Early extensive surgery in severe cases lowers risk of diabetes. Clinical Endocrinology. 2003;58:355–364
    • MEDLINE
    • CrossRef
15. Koivisto M, Blanco-Sequeiros M, Krause U. Neonatal symptomatic and asymptomatic hypoglycaemia: A follow-up study of 151 children. Developmental Medicine and Child Neurology. 1972;14:603–614
    • MEDLINE
    • CrossRef
16. Landau H, Perlman M, Meyer S, Isacsohn M, Krausz M, Mayan H, et al. Persistent neonatal hypoglycemia due to hyperinsulinism: Medical aspects. Pediatrics. 1982;70:440–446
    • MEDLINE
17. Lucas A, Morley R, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. British Medical Journal. 1988;297:1304–1308
18. Mahachoklertwattana P, Suprasongsin C, Teeraratkul S, Preeyasombat C. Persistent hyperinsulinemic hypoglycemia of infancy: Long-term outcome following subtotal pancreatectomy. Journal of Pediatric Endocrinology and Metabolism. 2000;13:37–44
19. Menni R, de Lonlay P, Sevin C, Touati G, Peigne C, Barbier V, et al. Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics. 2001;107:476–479
    • CrossRef
20. National Dissemination Center for Children with Disabilities . Who are the children in special education?. [Research Brief] 2003, June;Retrieved October 3, 2003, fromhttp://www.nichcy.org/pubs/research/rb2txt.htm
21. Philipson LH, Steiner DF. Pas de deux or more: The sulfonylurea receptor and K+ channels. Science. 1995;268:372–373
    • MEDLINE
    • CrossRef
22. Spitz L, Bhargava RK, Grant DB, Leonard JV. Surgical treatment of hyperinsulinaemic hypoglycaemia in infancy and childhood. Archives of Diseases in Children. 1992;67:201–205
23. Stanley CA. Hyperinsulinism in infants and children. Pediatric Clinics of North America. 1997;44:363–373
    • Abstract
    • Full Text
    • Full-Text PDF (674 KB)
    • CrossRef
24. Stanley CA, Baker L. Hyperinsulinism in infants and children: Diagnosis and treatment. Advanced Pediatrics. 1976;23:315–355
25. Stanley CA, Lieu YK, Hsu BYL, Burlina AB, Greenberg CR, Hopwood N, et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. New England Journal of Medicine. 1998;338:1352–1357
26. Stanley CA, Thornton PS, Finegold DN, Sperling MA. Hypoglycemia in neonates and infants. In:  Sperling MA editors. Pediatric endocrinology. 2nd ed.. Philadelphia: W.B. Saunders; 2002;p. 135–159
27. Stanley CA, Thornton PS, Ganguly A, MacMullen C, Underwood P, Bhatia P, et al. Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation. Journal of Clinical Endocrinology and Metabolism. 2004;89:288–296
28. Thomas CG, Cuenca RE, Azizkhan RG, Underwood LE, Carney CN. Changing concepts of islet cell dysplasia in neonatal and infantile hyperinsulinism. World Journal of Surgery. 1988;12:598–609
    • MEDLINE
    • CrossRef
29. Thornton PS, Finegold DN, Stanley CA, Sperling MA. Hypoglycemia in the infant and child. In:  Sperling MA editors. Pediatric endocrinology. 2nd ed.. Philadelphia: W.B. Saunders; 2002;p. 135–159
30. Thornton PS, MacMullen C, Ganguly A, Ruchelli E, Steinkrauss L, Crane A, et al. Clinical and molecular characterization of a dominant form of congenital hyperinsulinism caused by a mutation in the high affinity sulfonylurea receptor. Diabetes. 2003;52:2403–2410
    • MEDLINE
    • CrossRef